Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 44

Sort by

Sort Order Select

Journal Articles

Microscope diagnosis of MYH9-related thrombocytopenia

Alina Sadaf, Russell E. Ware

Blood (2021) 138 (11): 1000.

https://doi.org/10.1182/blood.2021012044

Published: 2021

Journal Articles

Pal K, Nowak R, Billington N, et al. Megakaryocyte migration defects due to nonmuscle myosin IIA mutations underlie thrombocytopenia in MYH9 -related disease. Blood. 2020;135(21):1887-1898.

Blood (2020) 136 (6): 771.

https://doi.org/10.1182/blood.2020007850

Published: 2020

Journal Articles

Megakaryocyte migration defects due to nonmuscle myosin IIA mutations underlie thrombocytopenia in MYH9 -related disease

Kasturi Pal, Roberta Nowak, Neil Billington, Rong Liu, Arit Ghosh, James R. Sellers, Velia M. Fowler

Blood (2020) 135 (21): 1887–1898.

https://doi.org/10.1182/blood.2019003064

Published: 2020

Includes: Multimedia, Supplemental data

Journal Articles

Pro-Platelet Formation Is Impaired in Megakaryocytes of MYH9 -Related Disease Patients

Chen-Cong Wang, Ya-Nan Wang, Qi Chen, Xiao Liu, Jia-Min Zhang, MD, Jing Xue, Hai-Xia Fu, Xiaosu Zhao, Shu-Ying Zheng, Xiang-Yu Zhao, Ying-Jun Chang, Kai-Yan Liu, Xiao-Jun Huang, MD, Xiaohui Zhang, MD

Blood (2017) 130 (Supplement 1): 1034.

https://doi.org/10.1182/blood.V130.Suppl_1.1034.1034

Published: 2017

Journal Articles

Gene Heterogenicity Diagnosis on Children with Complicated Immunological and Hematological Abnormalities

Chunfu Li, MD, Haixia Guo, MD PhD

Blood (2017) 130 (Supplement 1): 4946.

https://doi.org/10.1182/blood.V130.Suppl_1.4946.4946

Published: 2017

Journal Articles

Functional Characterization of a Novel GFI1B Mutation Causing Congenital Macrothrombocytopenia

Katsumasa Kitamura, MD, Yusuke Okuno, MD PhD, Kenichi Yoshida, MD PhD, Masashi Sanada, MD PhD, Yuichi Shiraishi, MD PhD, Hideki Muramatsu, MD PhD, Ryoji Kobayashi, MD PhD, Satoru Miyano, MD PhD, Seiji Kojima, MD PhD, Seishi Ogawa, MD PhD, Shinji Kunishima, PhD

Blood (2015) 126 (23): 75.

https://doi.org/10.1182/blood.V126.23.75.75

Published: 2015

Journal Articles

Myosin-II repression favors pre/proplatelets but shear activation generates platelets and fails in macrothrombocytopenia

Kyle R. Spinler, Jae-Won Shin, Michele P. Lambert, Dennis E. Discher

Blood (2015) 125 (3): 525–533.

https://doi.org/10.1182/blood-2014-05-576462

Published: 2015

Includes: Supplemental data

Journal Articles

Carboxyl-terminal-dependent recruitment of nonmuscle myosin II to megakaryocyte contractile ring during polyploidization

Idinath Badirou, Jiajia Pan, Céline Legrand, Aibing Wang, Larissa Lordier, Siham Boukour, Anita Roy, William Vainchenker, Yunhua Chang

Blood (2014) 124 (16): 2564–2568.

https://doi.org/10.1182/blood-2014-06-584995

Published: 2014

Includes: Supplemental data

Journal Articles

Molecular and clinical predictors of inhibitor risk and its prevention and treatment in mild hemophilia A

Giancarlo Castaman, Karin Fijnvandraat

Blood (2014) 124 (15): 2333–2336.

https://doi.org/10.1182/blood-2014-02-546127

Published: 2014

Journal Articles

Myosin IIA is critical for organelle distribution and F-actin organization in megakaryocytes and platelets

Fabien Pertuy, Anita Eckly, Josiane Weber, Fabienne Proamer, Jean-Yves Rinckel, François Lanza, Christian Gachet, Catherine Léon

Blood (2014) 123 (8): 1261–1269.

https://doi.org/10.1182/blood-2013-06-508168

Published: 2014

Includes: Multimedia, Supplemental data

Journal Articles

Human regulatory T cells against minor histocompatibility antigens: ex vivo expansion for prevention of graft-versus-host disease

Anandharaman Veerapathran, Joseph Pidala, Francisca Beato, Brian Betts, Jongphil Kim, Joel G. Turner, Marc K. Hellerstein, Xue-Zhong Yu, William Janssen, Claudio Anasetti

Blood (2013) 122 (13): 2251–2261.

https://doi.org/10.1182/blood-2013-03-492397

Published: 2013

Includes: Supplemental data

Journal Articles

Dysmegakaryopoiesis of FPD/AML pedigrees with constitutional RUNX1 mutations is linked to myosin II deregulated expression

Dominique Bluteau, Ana C. Glembotsky, Anna Raimbault, Nathalie Balayn, Laure Gilles, Philippe Rameau, Paquita Nurden, Marie Christine Alessi, Najet Debili, William Vainchenker, Paula G. Heller, Remi Favier, Hana Raslova

Blood (2012) 120 (13): 2708–2718.

https://doi.org/10.1182/blood-2012-04-422337

Published: 2012

Includes: Supplemental data

Journal Articles

Does “more” necessarily mean “better”?

Luciana Teofili, Luigi Maria Larocca

Blood (2012) 119 (14): 3194–3196.

https://doi.org/10.1182/blood-2012-02-406637

Published: 2012

Journal Articles

Romiplostim administration shows reduced megakaryocyte response-capacity and increased myelofibrosis in a mouse model of MYH9-RD

Catherine Léon, Katja Evert, Frank Dombrowski, Fabien Pertuy, Anita Eckly, Patricia Laeuffer, Christian Gachet, Andreas Greinacher

Blood (2012) 119 (14): 3333–3341.

https://doi.org/10.1182/blood-2011-08-373811

Published: 2012

Journal Articles

Mouse models of MYH9 -related disease: mutations in nonmuscle myosin II-A

Yingfan Zhang, Mary Anne Conti, Daniela Malide, Fan Dong, Aibing Wang, Yelena A. Shmist, Chengyu Liu, Patricia Zerfas, Mathew P. Daniels, Chi-Chao Chan, Elliot Kozin, Bechara Kachar, Michael J. Kelley, Jeffrey B. Kopp, Robert S. Adelstein

Blood (2012) 119 (1): 238–250.

https://doi.org/10.1182/blood-2011-06-358853

Published: 2012

Includes: Multimedia, Supplemental data

Journal Articles

Growth Factor Independence 1b (Gfi1b) Is An Essential Regulator of Late Stage Megakaryocyte Maturation and Platelet Production

Lothar Vassen, PhD, Tarik Moroy, Ph.D.

Blood (2011) 118 (21): 2358.

https://doi.org/10.1182/blood.V118.21.2358.2358

Published: 2011

Journal Articles

NEW FINDINGS From the FRENCH COHORT of MYH9-RELATED DISORDERS: PHENOTYPE PECULIARITIES and GENOTYPE NOVELTIES on Behalf of the National French Reference Center on Inherited Platelet Disorders (CRPP)

Béatrice Saposnik, PhD, Sylvie Binard, Alan T. Nurden, PhD, Paquita Nurden, MD, PhD, Nicole Schlegel, MD, PhD

Blood (2011) 118 (21): 1155.

https://doi.org/10.1182/blood.V118.21.1155.1155

Published: 2011

Journal Articles

RUNX1-Induced Silencing of Non-Muscle Myosin Iib (MYH10) Is Required for Megakaryocyte Polyploidization

Dominique Bluteau, PhD, Larissa Lordier, PhD, Iléana Antony-Debré, Abdelali Jalil, Céline Legrand, Philippe Rameau, Olivier Bluteau, PhD, Dima Jouni, Thomas Mercher, PhD, Catherine Leon, Christian Gachet, MD, PhD, Najet Debili, PhD, William Vainchenker, MD., Ph.D, Yunhua Chang, PhD, Hana Raslova, PhD

Blood (2011) 118 (21): 1308.

https://doi.org/10.1182/blood.V118.21.1308.1308

Published: 2011

Journal Articles

Abnormal Proplatelet Formation and Myosin Activation Status in Patients with MYH9-Related Syndrome

Yolande Chen, MD, Siham Boukour, PhD, Paquita Nurden, MD, PhD, Ababacar Seye, Olivier Bluteau, PhD, Alberta Palazzo, Yunhua Chang, PhD, Larissa Lordier, PhD, Remi Favier, MD, Nicole Schlegel, MD, PhD, Anne Galy, PharmD, PhD, Alan T. Nurden, PhD, Hana Raslova, PhD, William Vainchenker, MD, PhD, Najet Debili, PhD

Blood (2011) 118 (21): 4826.

https://doi.org/10.1182/blood.V118.21.4826.4826

Published: 2011

Journal Articles

Eltrombopag for the treatment of the inherited thrombocytopenia deriving from MYH9 mutations

Alessandro Pecci, Paolo Gresele, Catherine Klersy, Anna Savoia, Patrizia Noris, Tiziana Fierro, Valeria Bozzi, Anna Maria Mezzasoma, Federica Melazzini, Carlo L. Balduini

Blood (2010) 116 (26): 5832–5837.

https://doi.org/10.1182/blood-2010-08-304725

Published: 2010

Includes: Supplemental data

NARROW

Microscope diagnosis of MYH9-related thrombocytopenia

Pal K, Nowak R, Billington N, et al. Megakaryocyte migration defects due to nonmuscle myosin IIA mutations underlie thrombocytopenia in MYH9 -related disease. Blood. 2020;135(21):1887-1898.

Megakaryocyte migration defects due to nonmuscle myosin IIA mutations underlie thrombocytopenia in MYH9 -related disease

Pro-Platelet Formation Is Impaired in Megakaryocytes of MYH9 -Related Disease Patients

Gene Heterogenicity Diagnosis on Children with Complicated Immunological and Hematological Abnormalities

Functional Characterization of a Novel GFI1B Mutation Causing Congenital Macrothrombocytopenia

Myosin-II repression favors pre/proplatelets but shear activation generates platelets and fails in macrothrombocytopenia

Carboxyl-terminal-dependent recruitment of nonmuscle myosin II to megakaryocyte contractile ring during polyploidization

Molecular and clinical predictors of inhibitor risk and its prevention and treatment in mild hemophilia A

Myosin IIA is critical for organelle distribution and F-actin organization in megakaryocytes and platelets

Human regulatory T cells against minor histocompatibility antigens: ex vivo expansion for prevention of graft-versus-host disease

Dysmegakaryopoiesis of FPD/AML pedigrees with constitutional RUNX1 mutations is linked to myosin II deregulated expression

Does “more” necessarily mean “better”?

Romiplostim administration shows reduced megakaryocyte response-capacity and increased myelofibrosis in a mouse model of MYH9-RD

Mouse models of MYH9 -related disease: mutations in nonmuscle myosin II-A

Growth Factor Independence 1b (Gfi1b) Is An Essential Regulator of Late Stage Megakaryocyte Maturation and Platelet Production

NEW FINDINGS From the FRENCH COHORT of MYH9-RELATED DISORDERS: PHENOTYPE PECULIARITIES and GENOTYPE NOVELTIES on Behalf of the National French Reference Center on Inherited Platelet Disorders (CRPP)

RUNX1-Induced Silencing of Non-Muscle Myosin Iib (MYH10) Is Required for Megakaryocyte Polyploidization

Abnormal Proplatelet Formation and Myosin Activation Status in Patients with MYH9-Related Syndrome

Eltrombopag for the treatment of the inherited thrombocytopenia deriving from MYH9 mutations

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only